Ra Pharmaceuticals, Inc.. (RARX) NASDAQ

$48 0 (0.00%)

Market Cap: $2.26B

As of 04/01/20 12:00 AM EDT. Market closed.

(RARX)

Ra Pharmaceuticals, Inc.. (RARX) NASDAQ

$48 0 (0.00%)

Market Cap: $2.26B

As of 04/01/20 12:00 AM EDT. Market closed.

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, ... read more

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas A. Treco
Full Time Employees
89
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.98M
URL
Address
87 CambridgePark Drive, MA, Cambridge, 02140.
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas A. Treco
Full Time Employees
89
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.98M
Address
87 CambridgePark Drive, MA, Cambridge, 02140.
KEY STATS
Open
$0
Previous Close
$48
Days Range
$0 - $0
52 week range
$19.64 - $48.02
Volume
0
Avg. Volume (30 days)
1,446,350
Market Cap
$2.26B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,143,000
Open
$0
Previous Close
$48
Days Range
$0 - $0
52 week range
$19.64 - $48.02
Volume
0
Avg. Volume (30 days)
1,446,350
Market Cap
$2.26B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,143,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RA PHARMACEUTICALS, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Treco Douglas A President and CEO Apr 02, 2020 Option Exercise $48.00 234,707 11,265,936 0 Apr 03, 2020, 09:02 AM
Lubner David Charles Executive VP and CFO Apr 02, 2020 Option Exercise $48.00 15,622 749,856 0 Apr 03, 2020, 09:02 AM
Ricardo Alonso See Remarks Apr 02, 2020 Option Exercise $48.00 2,973 142,704 0 Apr 03, 2020, 09:02 AM
Read Simon Chief Scientific Officer Apr 02, 2020 Option Exercise $48.00 12,595 604,560 0 Apr 03, 2020, 09:02 AM
Farzaneh-Far Ramin Chief Medical Officer Apr 02, 2020 Option Exercise $48.00 14,492 695,616 0 Apr 03, 2020, 09:01 AM
King John C Chief Commercial Officer Apr 02, 2020 Option Exercise $48.00 10,823 519,504 0 Apr 03, 2020, 09:01 AM
Shah Rajeev M. Director Apr 02, 2020 Option Exercise $48.00 4,858,260 233,196,480 0 Apr 03, 2020, 09:00 AM
RA CAPITAL MANAGEMENT, L.P. Director Apr 02, 2020 Option Exercise $48.00 4,858,260 233,196,480 0 Apr 03, 2020, 12:00 AM
Ricardo Alonso See Remarks Mar 17, 2020 Sale $44.25 2,288 101,244 0 Mar 18, 2020, 06:00 PM
Farzaneh-Far Ramin Chief Medical Officer Mar 16, 2020 Option Exercise $5.60 10,595 59,332 17,727 Mar 18, 2020, 06:00 PM
Farzaneh-Far Ramin Chief Medical Officer Mar 16, 2020 Sale $45.16 10,595 478,521 7,132 Mar 18, 2020, 06:00 PM
Farzaneh-Far Ramin Chief Medical Officer Feb 18, 2020 Option Exercise $5.60 10,595 59,332 17,727 Feb 20, 2020, 06:52 PM
Farzaneh-Far Ramin Chief Medical Officer Feb 18, 2020 Sale $46.61 10,595 493,850 7,132 Feb 20, 2020, 06:52 PM
Ricardo Alonso See Remarks Jan 17, 2020 Sale $47.02 2,285 107,441 2,288 Jan 21, 2020, 06:32 PM
Farzaneh-Far Ramin Chief Medical Officer Jan 15, 2020 Option Exercise $5.60 10,595 59,332 17,727 Jan 16, 2020, 06:01 PM
Farzaneh-Far Ramin Chief Medical Officer Jan 15, 2020 Sale $46.95 10,595 497,441 7,132 Jan 16, 2020, 06:01 PM
Ricardo Alonso See Remarks Dec 17, 2019 Sale $47.08 2,285 107,568 4,573 Dec 18, 2019, 06:01 PM
Read Simon Chief Scientific Officer Dec 17, 2019 Option Exercise $2.87 10,000 28,700 16,234 Dec 18, 2019, 06:01 PM
Read Simon Chief Scientific Officer Dec 17, 2019 Sale $47.08 10,000 470,821 6,234 Dec 18, 2019, 06:01 PM
Farzaneh-Far Ramin Chief Medical Officer Dec 16, 2019 Option Exercise $5.60 10,595 59,332 17,727 Dec 18, 2019, 06:00 PM
Farzaneh-Far Ramin Chief Medical Officer Dec 16, 2019 Sale $47.23 10,595 500,351 7,132 Dec 18, 2019, 06:00 PM
Farzaneh-Far Ramin Chief Medical Officer Nov 15, 2019 Option Exercise $5.60 10,595 59,332 17,727 Nov 18, 2019, 05:08 PM
Farzaneh-Far Ramin Chief Medical Officer Nov 15, 2019 Sale $46.66 10,595 494,319 7,132 Nov 18, 2019, 05:08 PM
Read Simon Chief Scientific Officer Nov 14, 2019 Option Exercise $2.87 10,000 28,700 16,234 Nov 18, 2019, 05:07 PM
Read Simon Chief Scientific Officer Nov 14, 2019 Sale $46.68 10,000 466,808 6,234 Nov 18, 2019, 05:07 PM
Ricardo Alonso See Remarks Oct 17, 2019 Sale $46.70 2,285 106,710 6,858 Oct 17, 2019, 08:11 PM
Read Simon Chief Scientific Officer Oct 16, 2019 Option Exercise $2.87 10,000 28,700 16,234 Oct 17, 2019, 07:00 PM
Read Simon Chief Scientific Officer Oct 16, 2019 Sale $46.87 10,000 468,726 6,234 Oct 17, 2019, 07:00 PM
Farzaneh-Far Ramin Chief Medical Officer Oct 15, 2019 Option Exercise $5.60 10,595 59,332 17,727 Oct 17, 2019, 07:00 PM
Farzaneh-Far Ramin Chief Medical Officer Oct 15, 2019 Sale $46.89 10,595 496,769 7,132 Oct 17, 2019, 07:00 PM
Farzaneh-Far Ramin Chief Medical Officer Sep 16, 2019 Option Exercise $5.60 10,595 59,332 17,727 Sep 16, 2019, 06:44 PM
Farzaneh-Far Ramin Chief Medical Officer Sep 16, 2019 Sale $25.26 10,595 267,675 7,132 Sep 16, 2019, 06:44 PM
Read Simon Chief Scientific Officer Sep 12, 2019 Option Exercise $2.87 10,000 28,700 16,234 Sep 16, 2019, 06:43 PM
Read Simon Chief Scientific Officer Sep 12, 2019 Sale $25.41 10,000 254,050 6,234 Sep 16, 2019, 06:43 PM
Read Simon Chief Scientific Officer Aug 23, 2019 Option Exercise $2.87 10,000 28,700 16,234 Aug 27, 2019, 06:01 PM
Read Simon Chief Scientific Officer Aug 23, 2019 Sale $27.77 10,000 277,703 6,234 Aug 27, 2019, 06:01 PM
Farzaneh-Far Ramin Chief Medical Officer Aug 23, 2019 Option Exercise $5.60 10,595 59,332 17,727 Aug 27, 2019, 06:01 PM
Farzaneh-Far Ramin Chief Medical Officer Aug 23, 2019 Sale $27.77 10,595 294,226 7,132 Aug 27, 2019, 06:01 PM
Ricardo Alonso See Remarks Aug 23, 2019 Sale $27.89 2,285 63,740 9,143 Aug 27, 2019, 06:00 PM
Read Simon Chief Scientific Officer Jul 17, 2019 Option Exercise $2.87 10,000 28,700 16,234 Jul 18, 2019, 07:04 PM
Read Simon Chief Scientific Officer Jul 17, 2019 Sale $32.95 10,000 329,479 6,234 Jul 18, 2019, 07:04 PM
Farzaneh-Far Ramin Chief Medical Officer Jul 15, 2019 Option Exercise $5.60 10,595 59,332 17,727 Jul 16, 2019, 07:15 PM
Farzaneh-Far Ramin Chief Medical Officer Jul 15, 2019 Sale $33.10 10,595 350,647 11,348 Jul 16, 2019, 07:15 PM
Ricardo Alonso See Remarks Jun 21, 2019 Sale $23.72 2,857 67,782 11,428 Jun 25, 2019, 04:16 PM
Read Simon Chief Scientific Officer Jun 18, 2019 Option Exercise $2.87 10,000 28,700 16,234 Jun 19, 2019, 09:03 PM
Read Simon Chief Scientific Officer Jun 18, 2019 Sale $22.25 10,000 222,467 6,648 Jun 19, 2019, 09:03 PM
Farzaneh-Far Ramin Chief Medical Officer Jun 17, 2019 Option Exercise $5.60 10,595 59,332 17,727 Jun 19, 2019, 09:03 PM
Farzaneh-Far Ramin Chief Medical Officer Jun 17, 2019 Sale $21.84 10,595 231,384 14,316 Jun 19, 2019, 09:03 PM
King John C Chief Commercial Officer Apr 16, 2019 Option Exercise $21.93 4,506 98,817 10,823 Apr 18, 2019, 05:55 PM
Lubner David Charles Executive V.P. & CFO Feb 01, 2019 Option Exercise $21.00 3,291 69,111 7,126 Feb 05, 2019, 07:39 PM
Read Simon Chief Scientific Officer Feb 01, 2019 Option Exercise $21.00 2,933 61,593 6,234 Feb 05, 2019, 07:39 PM
Farzaneh-Far Ramin Chief Medical Officer Feb 01, 2019 Option Exercise $21.00 3,285 68,985 7,132 Feb 05, 2019, 07:38 PM
Treco Douglas A President and CEO Feb 01, 2019 Option Exercise $21.00 6,327 132,867 218,799 Feb 05, 2019, 07:38 PM
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner Dec 14, 2018 Buy $15.50 645,161 9,999,996 6,135,234 Dec 14, 2018, 06:22 PM
RA CAPITAL MANAGEMENT, LLC Director Dec 12, 2018 Buy $15.50 1,006,452 15,600,006 4,858,260 Dec 14, 2018, 06:17 PM
Shah Rajeev M. Director Dec 14, 2018 Buy $15.50 1,006,452 15,600,006 4,858,260 Dec 14, 2018, 06:14 PM
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner Feb 16, 2018 Buy $6.00 2,000,000 12,000,000 5,490,073 Feb 21, 2018, 04:19 PM
Shah Rajeev M. Director Feb 14, 2018 Buy $6.00 2,500,000 15,000,000 3,851,808 Feb 16, 2018, 04:42 PM
RA CAPITAL MANAGEMENT, LLC Director Feb 14, 2018 Buy $6.00 2,500,000 15,000,000 3,851,808 Feb 16, 2018, 04:42 PM
Novartis Bioventures Ltd 10% Owner Jun 16, 2017 Sale $21.24 53,200 1,130,207 2,254,677 Jun 20, 2017, 04:41 PM
Novartis Bioventures Ltd 10% Owner Jun 19, 2017 Sale $22.02 3,220 70,899 2,251,457 Jun 20, 2017, 04:41 PM
Novartis Bioventures Ltd 10% Owner Jun 08, 2017 Sale $22.00 700 15,400 2,307,877 Jun 12, 2017, 04:12 PM
Novartis Bioventures Ltd 10% Owner Jun 07, 2017 Sale $22.11 4,840 106,999 2,308,577 Jun 08, 2017, 04:33 PM
Novartis Bioventures Ltd 10% Owner Jun 06, 2017 Sale $22.98 7,274 167,161 2,313,417 Jun 08, 2017, 04:33 PM
Novartis Bioventures Ltd 10% Owner Jun 05, 2017 Sale $23.11 4,780 110,488 2,320,691 Jun 06, 2017, 04:27 PM
Novartis Bioventures Ltd 10% Owner Jun 02, 2017 Sale $23.47 14,867 348,949 2,325,471 Jun 06, 2017, 04:27 PM
Novartis Bioventures Ltd 10% Owner Jun 01, 2017 Sale $23.89 10,722 256,176 2,340,338 Jun 02, 2017, 04:25 PM
Novartis Bioventures Ltd 10% Owner May 31, 2017 Sale $23.94 35,539 850,896 2,351,060 Jun 02, 2017, 04:25 PM
Novartis Bioventures Ltd 10% Owner May 26, 2017 Sale $25.14 5,300 133,267 2,386,599 May 30, 2017, 04:29 PM
Novartis Bioventures Ltd 10% Owner May 25, 2017 Sale $25.00 53 1,325 2,391,899 May 30, 2017, 04:29 PM
Novartis Bioventures Ltd 10% Owner May 24, 2017 Sale $25.01 17,451 436,364 2,391,952 May 25, 2017, 04:57 PM
Novartis Bioventures Ltd 10% Owner May 18, 2017 Sale $25.50 9,019 229,964 2,409,403 May 22, 2017, 06:50 PM
Novartis Bioventures Ltd 10% Owner May 17, 2017 Sale $25.51 22,534 574,901 2,418,422 May 18, 2017, 04:36 PM
Novartis Bioventures Ltd 10% Owner May 16, 2017 Sale $26.33 20,081 528,725 2,440,956 May 18, 2017, 04:36 PM
Novartis Bioventures Ltd 10% Owner Feb 27, 2017 Sale $20.96 57,844 1,212,306 2,476,662 May 02, 2017, 05:22 PM
Novartis Bioventures Ltd 10% Owner Feb 24, 2017 Sale $20.93 5,398 113,000 2,534,506 May 02, 2017, 05:22 PM
Novartis Bioventures Ltd 10% Owner Feb 23, 2017 Sale $21.04 4,999 105,160 2,539,904 May 02, 2017, 05:22 PM
Novartis Bioventures Ltd 10% Owner Mar 01, 2017 Sale $20.91 7,778 162,658 2,461,037 May 02, 2017, 05:22 PM
Novartis Bioventures Ltd 10% Owner Feb 22, 2017 Sale $21.86 749 16,370 2,544,903 May 02, 2017, 05:22 PM
Novartis Bioventures Ltd 10% Owner Feb 28, 2017 Sale $20.86 7,847 163,670 2,468,815 May 02, 2017, 05:22 PM
Novo A/S 10% Owner Oct 31, 2016 Buy $13.00 246,154 3,200,002 2,031,562 Nov 02, 2016, 04:54 PM
Shah Rajeev M. Director Oct 31, 2016 Buy $13.00 161,538 2,099,994 1,351,808 Oct 31, 2016, 08:46 PM
RA CAPITAL MANAGEMENT, LLC Director Oct 31, 2016 Buy $13.00 161,538 2,099,994 1,351,808 Oct 31, 2016, 07:41 PM
Weller Harry R 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:52 PM
Weller Harry R 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:52 PM
Weller Harry R 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:52 PM
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner Oct 31, 2016 Buy $13.00 263,538 3,425,994 2,745,846 Oct 31, 2016, 04:51 PM
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner Oct 31, 2016 Sale $13.00 340 4,420 79,821 Oct 31, 2016, 04:51 PM
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner Oct 31, 2016 Option Exercise $0.07 63,019 4,411 80,161 Oct 31, 2016, 04:51 PM
Viswanathan Ravi 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:51 PM
Viswanathan Ravi 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:51 PM
Viswanathan Ravi 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:51 PM
SANDELL SCOTT D 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:51 PM
SANDELL SCOTT D 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:51 PM
SANDELL SCOTT D 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:51 PM
Lettmann Jason Director Oct 31, 2016 Buy $13.00 393,923 5,120,999 4,066,503 Oct 31, 2016, 04:51 PM
Lettmann Jason Director Oct 31, 2016 Sale $13.00 340 4,420 79,821 Oct 31, 2016, 04:51 PM
Lettmann Jason Director Oct 31, 2016 Option Exercise $0.07 63,019 4,411 80,161 Oct 31, 2016, 04:51 PM
MOTT DAVID M 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:51 PM
MOTT DAVID M 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:51 PM
MOTT DAVID M 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:51 PM
KOLLURI KRISHNA KITTU 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:50 PM
KOLLURI KRISHNA KITTU 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:50 PM
KOLLURI KRISHNA KITTU 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd 10% Owner Oct 31, 2016 Buy $13.00 84,615 1,099,995 2,545,652 Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd 10% Owner Oct 31, 2016 Sale $13.00 339 4,407 62,575 Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd 10% Owner Oct 31, 2016 Option Exercise $0.07 62,914 4,404 62,914 Oct 31, 2016, 04:50 PM
KERINS PATRICK J 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:50 PM
KERINS PATRICK J 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:50 PM
KERINS PATRICK J 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:50 PM
BASKETT FOREST 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:49 PM
BASKETT FOREST 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:49 PM
BASKETT FOREST 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:49 PM
BARRIS PETER J 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:49 PM
BARRIS PETER J 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:49 PM
BARRIS PETER J 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:49 PM
BARRETT M JAMES 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:48 PM
BARRETT M JAMES 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:48 PM
BARRETT M JAMES 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner Oct 31, 2016 Buy $13.00 338,462 4,400,006 3,490,073 Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner Oct 31, 2016 Sale $13.00 435 5,655 80,223 Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner Oct 31, 2016 Option Exercise $0.07 80,658 5,646 80,658 Oct 31, 2016, 04:48 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Treco Douglas A President and CEO 04/02/2020 11,265,936
Lubner David Charles Executive VP and CFO 04/02/2020 749,856
Ricardo Alonso See Remarks 04/02/2020 142,704
Read Simon Chief Scientific Officer 04/02/2020 604,560
Farzaneh-Far Ramin Chief Medical Officer 04/02/2020 695,616
King John C Chief Commercial Officer 04/02/2020 519,504
Shah Rajeev M. Director 04/02/2020 233,196,480
RA CAPITAL MANAGEMENT, L.P. Director 04/02/2020 233,196,480
Ricardo Alonso See Remarks 03/17/2020 101,244
Farzaneh-Far Ramin Chief Medical Officer 03/16/2020 59,332
Farzaneh-Far Ramin Chief Medical Officer 03/16/2020 478,521
Farzaneh-Far Ramin Chief Medical Officer 02/18/2020 59,332
Farzaneh-Far Ramin Chief Medical Officer 02/18/2020 493,850
Ricardo Alonso See Remarks 01/17/2020 107,441
Farzaneh-Far Ramin Chief Medical Officer 01/15/2020 59,332
Farzaneh-Far Ramin Chief Medical Officer 01/15/2020 497,441
Ricardo Alonso See Remarks 12/17/2019 107,568
Read Simon Chief Scientific Officer 12/17/2019 28,700
Read Simon Chief Scientific Officer 12/17/2019 470,821
Farzaneh-Far Ramin Chief Medical Officer 12/16/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 12/16/2019 500,351
Farzaneh-Far Ramin Chief Medical Officer 11/15/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 11/15/2019 494,319
Read Simon Chief Scientific Officer 11/14/2019 28,700
Read Simon Chief Scientific Officer 11/14/2019 466,808
Ricardo Alonso See Remarks 10/17/2019 106,710
Read Simon Chief Scientific Officer 10/16/2019 28,700
Read Simon Chief Scientific Officer 10/16/2019 468,726
Farzaneh-Far Ramin Chief Medical Officer 10/15/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 10/15/2019 496,769
Farzaneh-Far Ramin Chief Medical Officer 09/16/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 09/16/2019 267,675
Read Simon Chief Scientific Officer 09/12/2019 28,700
Read Simon Chief Scientific Officer 09/12/2019 254,050
Read Simon Chief Scientific Officer 08/23/2019 28,700
Read Simon Chief Scientific Officer 08/23/2019 277,703
Farzaneh-Far Ramin Chief Medical Officer 08/23/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 08/23/2019 294,226
Ricardo Alonso See Remarks 08/23/2019 63,740
Read Simon Chief Scientific Officer 07/17/2019 28,700
Read Simon Chief Scientific Officer 07/17/2019 329,479
Farzaneh-Far Ramin Chief Medical Officer 07/15/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 07/15/2019 350,647
Ricardo Alonso See Remarks 06/21/2019 67,782
Read Simon Chief Scientific Officer 06/18/2019 28,700
Read Simon Chief Scientific Officer 06/18/2019 222,467
Farzaneh-Far Ramin Chief Medical Officer 06/17/2019 59,332
Farzaneh-Far Ramin Chief Medical Officer 06/17/2019 231,384
King John C Chief Commercial Officer 04/16/2019 98,817
Lubner David Charles Executive V.P. & CFO 02/01/2019 69,111
Read Simon Chief Scientific Officer 02/01/2019 61,593
Farzaneh-Far Ramin Chief Medical Officer 02/01/2019 68,985
Treco Douglas A President and CEO 02/01/2019 132,867
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner 12/14/2018 9,999,996
RA CAPITAL MANAGEMENT, LLC Director 12/12/2018 15,600,006
Shah Rajeev M. Director 12/14/2018 15,600,006
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner 02/16/2018 12,000,000
Shah Rajeev M. Director 02/14/2018 15,000,000
RA CAPITAL MANAGEMENT, LLC Director 02/14/2018 15,000,000
Novartis Bioventures Ltd 10% Owner 06/16/2017 1,130,207
Novartis Bioventures Ltd 10% Owner 06/19/2017 70,899
Novartis Bioventures Ltd 10% Owner 06/08/2017 15,400
Novartis Bioventures Ltd 10% Owner 06/07/2017 106,999
Novartis Bioventures Ltd 10% Owner 06/06/2017 167,161
Novartis Bioventures Ltd 10% Owner 06/05/2017 110,488
Novartis Bioventures Ltd 10% Owner 06/02/2017 348,949
Novartis Bioventures Ltd 10% Owner 06/01/2017 256,176
Novartis Bioventures Ltd 10% Owner 05/31/2017 850,896
Novartis Bioventures Ltd 10% Owner 05/26/2017 133,267
Novartis Bioventures Ltd 10% Owner 05/25/2017 1,325
Novartis Bioventures Ltd 10% Owner 05/24/2017 436,364
Novartis Bioventures Ltd 10% Owner 05/18/2017 229,964
Novartis Bioventures Ltd 10% Owner 05/17/2017 574,901
Novartis Bioventures Ltd 10% Owner 05/16/2017 528,725
Novartis Bioventures Ltd 10% Owner 02/27/2017 1,212,306
Novartis Bioventures Ltd 10% Owner 02/24/2017 113,000
Novartis Bioventures Ltd 10% Owner 02/23/2017 105,160
Novartis Bioventures Ltd 10% Owner 03/01/2017 162,658
Novartis Bioventures Ltd 10% Owner 02/22/2017 16,370
Novartis Bioventures Ltd 10% Owner 02/28/2017 163,670
Novo A/S 10% Owner 10/31/2016 3,200,002
Shah Rajeev M. Director 10/31/2016 2,099,994
RA CAPITAL MANAGEMENT, LLC Director 10/31/2016 2,099,994
Weller Harry R 10% Owner 10/31/2016 4,400,006
Weller Harry R 10% Owner 10/31/2016 5,655
Weller Harry R 10% Owner 10/31/2016 5,646
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner 10/31/2016 3,425,994
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner 10/31/2016 4,420
MORGENTHALER VENTURE PARTNERS IX LP 10% Owner 10/31/2016 4,411
Viswanathan Ravi 10% Owner 10/31/2016 4,400,006
Viswanathan Ravi 10% Owner 10/31/2016 5,655
Viswanathan Ravi 10% Owner 10/31/2016 5,646
SANDELL SCOTT D 10% Owner 10/31/2016 4,400,006
SANDELL SCOTT D 10% Owner 10/31/2016 5,655
SANDELL SCOTT D 10% Owner 10/31/2016 5,646
Lettmann Jason Director 10/31/2016 5,120,999
Lettmann Jason Director 10/31/2016 4,420
Lettmann Jason Director 10/31/2016 4,411
MOTT DAVID M 10% Owner 10/31/2016 4,400,006
MOTT DAVID M 10% Owner 10/31/2016 5,655
MOTT DAVID M 10% Owner 10/31/2016 5,646
KOLLURI KRISHNA KITTU 10% Owner 10/31/2016 4,400,006
KOLLURI KRISHNA KITTU 10% Owner 10/31/2016 5,655
KOLLURI KRISHNA KITTU 10% Owner 10/31/2016 5,646
Novartis Bioventures Ltd 10% Owner 10/31/2016 1,099,995
Novartis Bioventures Ltd 10% Owner 10/31/2016 4,407
Novartis Bioventures Ltd 10% Owner 10/31/2016 4,404
KERINS PATRICK J 10% Owner 10/31/2016 4,400,006
KERINS PATRICK J 10% Owner 10/31/2016 5,655
KERINS PATRICK J 10% Owner 10/31/2016 5,646
BASKETT FOREST 10% Owner 10/31/2016 4,400,006
BASKETT FOREST 10% Owner 10/31/2016 5,655
BASKETT FOREST 10% Owner 10/31/2016 5,646
BARRIS PETER J 10% Owner 10/31/2016 4,400,006
BARRIS PETER J 10% Owner 10/31/2016 5,655
BARRIS PETER J 10% Owner 10/31/2016 5,646
BARRETT M JAMES 10% Owner 10/31/2016 4,400,006
BARRETT M JAMES 10% Owner 10/31/2016 5,655
BARRETT M JAMES 10% Owner 10/31/2016 5,646
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner 10/31/2016 4,400,006
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner 10/31/2016 5,655
NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner 10/31/2016 5,646
Load More Insider Transactions